Chair: Prof. Shinji Yamashita (Japan)
The Bioavailability/Bioequivalence Focus Group (BA/BE FG) is part of the SIG on Regulatory Science in the Board of Pharmaceutical Sciences. It aims to offer up-to-date information on BA/BE of oral drugs and to discuss the international harmonization in regulating and controlling the quality of oral drug products.
Goals of BA/BE FG are:
▪ Understanding up-to-date Science and Technology relating to oral BA of drugs for contributing to the development of effective and safe oral drug products.
▪ Understanding the current status of Regulatory issues for oral drug products and proposing international standards.